Skip to content

Clinical trials

Phase 3 Peptic Ulcer trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Peptic Ulcer Phase: Phase 3 Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20031
20041
20051
20073
20081
20101
20121
20211
20242
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Recruiting2
Unknown status2
Not yet recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Daewoong Pharmaceutical Co. LTD.2
Il-Yang Pharm. Co., Ltd.2
Takeda2
Amgen1
AstraZeneca1
Casa Sollievo della Sofferenza IRCCS1
Chinese University of Hong Kong1
Cogentus Pharmaceuticals1
National Taiwan University Hospital1
Onconic Therapeutics Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Peptic Ulcer14
Duodenal Ulcer4
Gastroesophageal Reflux3
Stomach Ulcer3
Gastrointestinal Hemorrhage2
Osteoarthritis2
Acute Coronary Syndrome1
Arthritis1
Arthritis, Rheumatoid1
Cerebrovascular Disorders1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.